Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Resmed (RMD) -- Ignore unavailable to you. Want to Upgrade?

To: Angelo Ferraro who wrote (5)	8/21/2000 12:12:42 AM
From: Henrik	Respond to of 8

Makes Fortune Fast Growth List RESMED INC 2000-08-21 ASX-SIGNAL-G HOMEX - Sydney ResMed Inc (ASX: RMD) announced today that it has again been included in FORTUNE Magazine's annual list of the 100 Fastest Growing Companies in the US. This is the second consecutive year that ResMed has been included in the list, which evaluates companies on profit and revenue growth over the past three years as well as stock market returns. Peter C Farrell, Ph D ResMed's Founder, Chairman and CEO, stated: "We are delighted to have again been included on FORTUNE'S list. It speaks well of both ResMed and the growing importance of sleep-disordered breathing." The Company also announced that Dr Farrell, along with the Chairman of ResMed's Medical Advisory Board, Professor Colin Sullivan, have jointly been awarded the Year 2000 KL Sutherland Memorial Medal for the invention, development and commercialization of nasal Continuous Positive Airway Pressure (CPAP) for the treatment of obstructive sleep apnea. Professor Sullivan, from the University of Sydney, was the inventor of nasal CPAP therapy in the early 1980s and ResMed, under the leadership of Dr Farrell, has successfully developed innovative products, based on Colin Sullivan's invention, which are now sold in over 50 countries. The KL Sutherland Memorial Medal is awarded biennially, for achievement in the application of science for the benefit of the community, by the Australian Industrial Research Group, The Australasian Institute of Mining and Metallurgy and the Australian Academy of Technological Sciences and Engineering. Finally, the Company announced that Dr Farrell has accepted an invitation to serve as Vice-Chair of the Executive Council of the Division of Sleep Medicine of the Harvard Medical School. Dr Farrell commented: "I am pleased to have been invited to work with a first-class group of individuals at Harvard Medical School with the goal of cementing a place for the study of sleep disorders within the medical field. ResMed is a leading developer, manufacturer, and marketer of medical equipment for the diagnosis and treatment of sleep-disordered breathing, a disorder that affects 20 million Americans alone. ResMed has made the Forbes' list of 200 Best Small Companies in America for three consecutive years; in 1999, ResMed was ranked #27 up from #172 in 1997. In both 1999 and 2000, ResMed also was listed as one of Business Week's Hundred Hot Growth Companies. Further information can be obtained by contacting Brett Sandercock at ResMed at 02 9886 5406 or by visiting the Company's web site at www.resmed.com.